(MRSK) Northern Lights Fund Trust - Overview
Etf: ETF, Options, Futures, Stocks, Bonds
Dividends
| Dividend Yield | 0.37% |
| Yield on Cost 5y | 0.56% |
| Yield CAGR 5y | -57.38% |
| Payout Consistency | 76.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.0% |
| Relative Tail Risk | 2.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.56 |
| Alpha | 0.74 |
| Character TTM | |
|---|---|
| Beta | 0.507 |
| Beta Downside | 0.416 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.22% |
| CAGR/Max DD | 1.03 |
Description: MRSK Northern Lights Fund Trust December 30, 2025
The Northern Lights Fund Trust (NYSE ARCA:MRSK) pursues its equity-hedged objective by allocating across a broad set of instruments-including common stocks, equity and fixed-income ETFs, cash equivalents, as well as derivatives such as equity index futures, equity index options, and options on ETFs-allowing the manager to dynamically hedge market exposure while retaining upside potential.
Key metrics (as of the most recent filing) show an expense ratio of roughly 0.45% and assets under management near $150 million, with a typical hedge ratio of about 70 % of net assets. The fund’s performance is closely tied to U.S. equity market volatility (VIX) and the term structure of interest rates, since its hedging overlay relies on futures and options that are sensitive to both equity and fixed-income market conditions. Recent sector allocations have favored technology and consumer discretionary, reflecting the broader macro trend of discretionary spending growth amid a still-tight labor market.
For a deeper, data-driven comparison of MRSK’s risk-adjusted returns versus peers, you might find ValueRay’s analytics platform worth a quick look.
What is the price of MRSK shares?
Over the past week, the price has changed by -0.43%, over one month by -0.13%, over three months by +3.67% and over the past year by +10.49%.
Is MRSK a buy, sell or hold?
What are the forecasts/targets for the MRSK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 41.1 | 10.7% |
MRSK Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 308.8m USD (308.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 308.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 308.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.78% (E(308.8m)/V(308.8m) * Re(7.78%) + (debt-free company))
Discount Rate = 7.78% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)